Administration
J. Douglas Bricker, Ph.D. Dean
Mylan School of Pharmacy and the Graduate School of Pharmaceutical Sciences

James K. Drennen, Ph.D., Associate Dean for Graduate Programs and Research
Mylan School of Pharmacy and the Graduate School of Pharmaceutical Sciences

David A. Johnson, Ph.D., Director of Graduate Studies
Graduate School of Pharmaceutical Sciences

Medicinal Chemistry
Aleem Gangjee, Professor of Medicinal Chemistry; Mylan School of Pharmacy Distinguished Professor, Ph.D., Iowa . Synthetic medicinal chemistry, computer-assisted drug design, inhibitors of folate metabolizing enzymes, receptor tyronsine kinase inhibitors, antimitotic agents, antitumor agents, antiopportunistic infection agents, nucleosides, heterocyclic chemistry and stereochemistry.

Patrick Flaherty, Assistant Professor of Medicinal Chemistry; Ph.D., Iowa. Synthetic medicinal chemistry and rational drug design, emphasis on emerging biochemical targets relevant to human disease states, modern synthetic methodology, and iterative rounds of computation, synthesis, then biochemical analysis; general therapeutic areas of interest are CNS agents and anti-cancer agents; current biological target are CDK5, microtubules, DXR, and alpha-synuclein.

Marc W. Harrold, Professor of Medicinal Chemistry; Ph.D., Ohio State. Development of computer-based educational tools, instructional strategies in medicinal chemistry, drug design.

David J Lapinsky, Assistant Professor of Medicinal Chemistry; Ph.D.

Pharmaceutics
Moji Christianah Adeyeye, Professor of Pharmaceutics; Ph.D., Georgia. Preformulation, development, stability and bioavailability evaluation of immediate and sustained released liquid, semi-solid and solid dosage forms, excipient characterization, biopharmaceutical product technology, unit process optimization; anti-retroviral pediatric dosage forms.

Carl A. Anderson, Assistant Professor of Pharmaceutical Sciences; Ph.D., Texas (Austin). Sensor technology for the study and control of pharmaceutical manufacturing, employing technologies such as acoustic and near-infrared spectroscopy processed by using chemometric techniques.

Lawrence H. Block, Professor of Pharmaceutics; Ph.D., Maryland. Theoretical aspects of pharmacokinetics and pharmacodynamics; controlled and modified release drug and cosmetic delivery system development; excipient chracterizaton; pharmaceutic aspects of chitin, chitosan, and chitinosans; pharmaceutical engineering, especially scale-up of processing of non-parenteral liquids and semi-solids; and hydrophilic gels as drug delivery systems.

James K. Drennen, Associate Professor of Pharmaceutics,Ph.D., Kentucky. Pharmaceutical and medical applications of near-infrared spectroscopy, process control., chemometrics, process analytical technology.

Peter Wildfong, Assistant Professor of Pharmaceutics; Ph.D., Purdue.  Pharmaceutical materials science, with current research projects exploring how specific physiochemical and structural properties of pharmaceutically relevant materials impact large-scale manufacturing and final dosage from performance; emphasis on mechanically activated solid state phase transformation of APIs and excipients; investigating the potential of high-shear induction of polymorphism and amorphization.

Pharmacology
J. Douglas Bricker, Associate Professor of Pharmacology-Toxicology; Ph.D. Duquesne.  Effects of drugs, chemicals, and disease states on the regulation of calcium uptake mechanisms, development and screening of antidotal agents for clinical use, in vitro toxicity testing methods.

Vicki L. Davis, Assistant Professor of Pharmacology; Ph.D., North Carolina. Effects of pharmaceutical, environmental, plant and natural estrogens exposure on the development of breast cancer and cataracts in women, with emphasis on using various techniques to determine potential methods of decreasing the risk factors.

David A. Johnson, Associate Professor of Pharmacology-Toxicology; Ph.D., Massachusetts College of Pharmacy and Allied Health Sciences. Drugs which enhance the function of neuronal pathways involved with learning and memory, neuro-pathology and the treatment of eating disorders.

Wilson S. Meng, Associate Professor of Pharmaceutical Sciences (Pharmacology-Toxicology and Pharmaceuties); Ph.D., Southern California. Structure-base design of tumor reactive T-cell epitopes and development of particle-based DNA delivery systems.

Christopher K. Surratt, Associate Professor of Pharmacology; Ph.D., Virginia. Structure-function studies on brain receptors that recognize psychostimulant and opiate drugs of abuse.

Paula A. Witt-Enderby, Associate Professor of Pharmacology-Toxicology; Ph.D., Arizona. Molecular pharmacology of melatonin receptors and its associated signaling cascades with emphasis on the role melatonin in stem cell differentiation.

Pharmaceutical Administration
Vincent J. Giannetti, Professor of Pharmaceutical Administration; Ph.D., Pittsburgh. Prescription drug adherence, mental health, substance abuse, pharmacist counseling behaviors, health care policy and ethics, coping with medication errors.

Khalid M. Kamal, Assistant Professor of Pharmaceutical Administration; Ph.D., West Virginia. Application of decision and cost-effectiveness analysis in health policy and medicine; health outcomes assessment in chronic conditions as rheumatoid arthritis, ankylosing spondylitis, chronic obstructive pulmonary disease.

David J. Tipton, Associate Professor of Pharmaceutical Administration; Ph.D., St. Louis. Medication errors, services marketing, emotional intelligence.